ZURA: Zura Bio Company Short-Term Debt
This chart of Zura Bio Limited (ZURA) value on GURU.Markets, where the indicator stands at 0.00, is based on the successes of this innovator in autoimmune pathology therapy, which has earned scientific recognition. The business is protected by an antibody patent portfolio and high trial costs, which limit competition. Consequently, Zura Bio Limited (ZURA) creates innovative tools for strengthening immunity and combating severe diseases.
Metric breakdowns and analytics for Zura Bio Ltd (ZURA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Zura Bio Limited|ZURA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Zura Bio Limited|ZURA - Company Total Debt|Debt to Book Capitalization Ratio Zura Bio Limited|ZURA - Company Long-Term Liabilities|Company Current Liabilities Zura Bio|Quick Liquidity zurabio.com
- net income and valuation multiples indicators:
Initial company analysis:ZURA - Zura Bio
Short-term debt reflects the company's obligations with a maturity period of up to one year, measuring the business's reliance on external working capital financing. This metric allows an investor to assess liquidity risk and resilience to cash flow gaps. By analyzing short-term borrowing volumes, one can determine the efficiency of current liability management. For Zura Bio Limited (ZURA), a low debt load is critical during antibody development. Unique molecule licenses minimize pricing risks, stabilizing the financial profile.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|Current Liabilities ZBIO|IMNM (Immunome, Inc.) - Company Current Liabilities|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|SEPN: Company Short-Term Loans and Borrowings|Company Short-Term Debts PVLA|Company Short-Term Debts Savara Pharma (SVRA)|Rigel Pharmaceuticals - Company Current Liabilities|Company Short-Term Loans and Borrowings ANAB|Astria Therapeutics, Inc. - Company Short-Term Debts|ENGN: Company Short-Term Debt|RAPT: Company Short-Term Debts|JBIO - Short-Term Debt Volume|Company Short-Term Debt Aclaris Therapeutics|Short-Term Debt kyvernatx.com KYTX|Company Current Liabilities TLSA (Tiziana Life Sciences Ltd)|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Ventyx Bio VTYX|Theratechnologies, Inc - Company Short-Term Debt|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt Volume eledon.com ELDN|Agenus Inc. (AGEN) - Company Short-Term Debt|Company Current Liabilities Climb Bio Inc.|ATYR (aTyr) - Company Short-Term Debts|Adagene Corp (ADAG) - Short-Term Debt Volume|Company Current Liabilities IMA (ImageneBio Inc)|Amount of Current Liabilities STTK|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|Immunic Inc - Company Short-Term Debts|ATRA (Atara Biotherapeutics) - Company Short-Term Indebtedness|IFRX (inflarx.de) - Company Current Liabilities|Current Liabilities XFOR (x4pharma.com)|Company Current Liabilities ACET|Company Short-Term Debts Celularity Corp|Company Short-Term Debt INmune Bio Corp (INMB)|BRNS (Barinthus Biotherapeutics Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debt|Current Liabilities ENLV|QTTB: Company Short-Term Debts|GeoVax Corp - Company Short-Term Loans and Borrowings|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Short-Term Debts ibioinc.com|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB - Company Current Liabilities|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|ADTX (aditxt.com) - Company Current Liabilities|GRI Bio Inc - Company Short-Term Loans and Borrowings|XRTX (XORTX) - Company Short-Term Debts|Vyome Therapeutics (HIND) - Short-Term Debt Volume|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Current Liabilities|AFMD: Company Current Liabilities|ALLK - Company Short-Term Debts|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Short-Term Indebtedness IGMS|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Ocean Biomedical Inc OCEA|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|THRD: Current Liabilities